NFKB1 and cancer: To ensure that NF-κB activation also occurred in cancer cells in an eEF1A2-dependent fashion, wt and APL-R HeLa cells were treated with 450 nM plitidepsin for the indicated times and the levels of IκB checked by Western blot.